Toripalimab
Records for this ingredient, by country (identity only).
ATC L01FF13 · 9 markets · 13 records
AU 3 records · 2 shown of 2
- 240 mg/6 mLinjectionZytorvi
- 240 mg per mL / per unit basis not statedinjectionZYTORVI toripalimab 240 mg/ 6 mL concentrated injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CN 3 records · 3 shown of 3
US 1 records · 1 shown of 1
- 240 mg/6 mLinjectionLOQTORZI
GB 1 records · 1 shown of 1
- 240 mg/6 mLinjectionLoqtorzi 240mg/6ml concentrate for solution for infusion vials
CA 1 records · 1 shown of 1
- 40 mg per mL / per unit basis not statedliquidLOQTORZI
SG 1 records · 1 shown of 1
- 240 mg/6 mLinjectionLOQTORZI CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/6ML
ES 1 records · 1 shown of 1
- 240 mg per mL / per unit basis not statedinjectionLOQTORZI
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 240 mg/6 mL injection | LOQTORZI | Loqtorzi 240mg/6ml concentrate for solution for infusion vials | Zytorvi | LOQTORZI CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/6ML | |||||
| 240 mg per mL / per unit basis not stated cannot compare injection | ZYTORVI toripalimab 240 mg/ 6 mL concentrated injection vial | 拓益特瑞普利单抗 | LOQTORZI | ||||||
| 40 mg per mL / per unit basis not stated cannot compare liquid | LOQTORZI | ||||||||
| 100 mg per mL / per unit basis not stated cannot compare injection | 拓益特瑞普利单抗 | ||||||||
| 80 mg per mL / per unit basis not stated cannot compare injection | 拓益特瑞普利单抗 | ||||||||
unknown | Zytorvi | LOQTORZI CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/6ML | LOQTORZI |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in CA and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en CA que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 CA 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 CA 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.